APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Pain Medicines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global OTC Pain Medicines Market Analysis and Forecast 2026-2032

2 January 2026208 pages

Choose your research edition.

Industry ResearchOTC Pain Medicines Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Pain Medicines Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal OTC Pain Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Pain Medicines Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Pain Medicines Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global OTC Pain Medicines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for OTC Pain Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for OTC Pain Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for OTC Pain Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for OTC Pain Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of OTC Pain Medicines include Zhejiang Kangle, Xinhua Pharmaceutical, Sanofi, Novartis, Pfizer, Hebei Jiheng, GlaxoSmithKline, Bayer and Anhui BBCA Likang, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for OTC Pain Medicines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of OTC Pain Medicines, also provides the revenue of main regions and countries. Of the upcoming market potential for OTC Pain Medicines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the OTC Pain Medicines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global OTC Pain Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for OTC Pain Medicines revenue, projected growth trends, production technology, application and end-user industry.

OTC Pain Medicines Segment by Company

Zhejiang Kangle

Xinhua Pharmaceutical

Sanofi

Novartis

Pfizer

Hebei Jiheng

GlaxoSmithKline

Bayer

Anhui BBCA Likang

Strides Shasun

Sri Krishna Pharma

Seqens

Mallinckrodt

IOLCP

Granules India

Granules Biocause

Farmson

Anqiu Lu'an

OTC Pain Medicines Segment by Type

Naproxen

Acetaminophen

Ibuprofen

Aspirin

Others

OTC Pain Medicines Segment by Application

E-Commerce

Drug Stores

Hospital Pharmacies

OTC Pain Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Pain Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Pain Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Pain Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of OTC Pain Medicines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of OTC Pain Medicines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Pain Medicines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global OTC Pain Medicines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Naproxen Major Player Table 3. Acetaminophen Major Player Table 4. Ibuprofen Major Player Table 5. Aspirin Major Player Table 6. Others Major Player Table 7. Global OTC Pain Medicines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. E-Commerce Major Player Table 9. Drug Stores Major Player Table 10. Hospital Pharmacies Major Player Table 11. OTC Pain Medicines Industry Trends Table 12. OTC Pain Medicines Industry Drivers Table 13. OTC Pain Medicines Industry Opportunities and Challenges Table 14. OTC Pain Medicines Industry Restraints Table 15. Global OTC Pain Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global OTC Pain Medicines Market Size by Region (2021-2026) & (US$ Million) Table 17. Global OTC Pain Medicines Market Share by Region (2021-2026) Table 18. Global OTC Pain Medicines Market Size by Region (2027-2032) & (US$ Million) Table 19. Global OTC Pain Medicines Market Share by Region (2027-2032) Table 20. Global OTC Pain Medicines Revenue by Players (US$ Million) & (2021-2026) Table 21. Global OTC Pain Medicines Revenue Market Share by Players (2021-2026) Table 22. Global OTC Pain Medicines Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global OTC Pain Medicines Key Players Headquarters & Area Served Table 24. Global OTC Pain Medicines Players, Product Type & Application Table 25. Global OTC Pain Medicines Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global OTC Pain Medicines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global OTC Pain Medicines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global OTC Pain Medicines Revenue by Type (2021-2026) & (US$ Million) Table 30. Global OTC Pain Medicines Revenue by Type (2027-2032) & (US$ Million) Table 31. Global OTC Pain Medicines Revenue Market Share by Type (2021-2026) Table 32. Global OTC Pain Medicines Revenue Market Share by Type (2027-2032) Table 33. Global OTC Pain Medicines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global OTC Pain Medicines Revenue by Application (2021-2026) & (US$ Million) Table 35. Global OTC Pain Medicines Revenue by Application (2027-2032) & (US$ Million) Table 36. Global OTC Pain Medicines Revenue Market Share by Application (2021-2026) Table 37. Global OTC Pain Medicines Revenue Market Share by Application (2027-2032) Table 38. Zhejiang Kangle Company Information Table 39. Zhejiang Kangle Business Overview Table 40. Zhejiang Kangle OTC Pain Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Zhejiang Kangle OTC Pain Medicines Product Portfolio Table 42. Zhejiang Kangle Recent Development Table 43. Xinhua Pharmaceutical Company Information Table 44. Xinhua Pharmaceutical Business Overview Table 45. Xinhua Pharmaceutical OTC Pain Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Xinhua Pharmaceutical OTC Pain Medicines Product Portfolio Table 47. Xinhua Pharmaceutical Recent Development Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi OTC Pain Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Sanofi OTC Pain Medicines Product Portfolio Table 52. Sanofi Recent Development Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis OTC Pain Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Novartis OTC Pain Medicines Product Portfolio Table 57. Novartis Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer OTC Pain Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Pfizer OTC Pain Medicines Product Portfolio Table 62. Pfizer Recent Development Table 63. Hebei Jiheng Company Information Table 64. Hebei Jiheng Business Overview Table 65. Hebei Jiheng OTC Pain Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Hebei Jiheng OTC Pain Medicines Product Portfolio Table 67. Hebei Jiheng Recent Development Table 68. GlaxoSmithKline Company Information Table 69. GlaxoSmithKline Business Overview Table 70. GlaxoSmithKline OTC Pain Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. GlaxoSmithKline OTC Pain Medicines Product Portfolio Table 72. GlaxoSmithKline Recent Development Table 73. Bayer Company Information Table 74. Bayer Business Overview Table 75. Bayer OTC Pain Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Bayer OTC Pain Medicines Product Portfolio Table 77. Bayer Recent Development Table 78. Anhui BBCA Likang Company Information Table 79. Anhui BBCA Likang Business Overview Table 80. Anhui BBCA Likang OTC Pain Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Anhui BBCA Likang OTC Pain Medicines Product Portfolio Table 82. Anhui BBCA Likang Recent Development Table 83. Strides Shasun Company Information Table 84. Strides Shasun Business Overview Table 85. Strides Shasun OTC Pain Medicines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Strides Shasun OTC Pain Medicines Product Portfolio Table 87. Strides Shasun Recent Development Table 88. Sri Krishna Pharma Company Information Table 89. Sri Krishna Pharma Business Overview Table 90. Sri Krishna Pharma OTC Pain Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sri Krishna Pharma OTC Pain Medicines Product Portfolio Table 92. Sri Krishna Pharma Recent Development Table 93. Seqens Company Information Table 94. Seqens Business Overview Table 95. Seqens OTC Pain Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Seqens OTC Pain Medicines Product Portfolio Table 97. Seqens Recent Development Table 98. Mallinckrodt Company Information Table 99. Mallinckrodt Business Overview Table 100. Mallinckrodt OTC Pain Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Mallinckrodt OTC Pain Medicines Product Portfolio Table 102. Mallinckrodt Recent Development Table 103. IOLCP Company Information Table 104. IOLCP Business Overview Table 105. IOLCP OTC Pain Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. IOLCP OTC Pain Medicines Product Portfolio Table 107. IOLCP Recent Development Table 108. Granules India Company Information Table 109. Granules India Business Overview Table 110. Granules India OTC Pain Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Granules India OTC Pain Medicines Product Portfolio Table 112. Granules India Recent Development Table 113. Granules Biocause Company Information Table 114. Granules Biocause Business Overview Table 115. Granules Biocause OTC Pain Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Granules Biocause OTC Pain Medicines Product Portfolio Table 117. Granules Biocause Recent Development Table 118. Farmson Company Information Table 119. Farmson Business Overview Table 120. Farmson OTC Pain Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Farmson OTC Pain Medicines Product Portfolio Table 122. Farmson Recent Development Table 123. Anqiu Lu'an Company Information Table 124. Anqiu Lu'an Business Overview Table 125. Anqiu Lu'an OTC Pain Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Anqiu Lu'an OTC Pain Medicines Product Portfolio Table 127. Anqiu Lu'an Recent Development Table 128. North America OTC Pain Medicines Revenue by Type (2021-2026) & (US$ Million) Table 129. North America OTC Pain Medicines Revenue by Type (2027-2032) & (US$ Million) Table 130. North America OTC Pain Medicines Revenue by Application (2021-2026) & (US$ Million) Table 131. North America OTC Pain Medicines Revenue by Application (2027-2032) & (US$ Million) Table 132. North America OTC Pain Medicines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. North America OTC Pain Medicines Revenue by Country (2021-2026) & (US$ Million) Table 134. North America OTC Pain Medicines Revenue by Country (US$ Million) & (2027-2032) Table 135. Europe OTC Pain Medicines Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe OTC Pain Medicines Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe OTC Pain Medicines Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe OTC Pain Medicines Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe OTC Pain Medicines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe OTC Pain Medicines Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe OTC Pain Medicines Revenue by Country (US$ Million) & (2027-2032) Table 142. China OTC Pain Medicines Revenue by Type (2021-2026) & (US$ Million) Table 143. China OTC Pain Medicines Revenue by Type (2027-2032) & (US$ Million) Table 144. China OTC Pain Medicines Revenue by Application (2021-2026) & (US$ Million) Table 145. China OTC Pain Medicines Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia OTC Pain Medicines Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia OTC Pain Medicines Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia OTC Pain Medicines Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia OTC Pain Medicines Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia OTC Pain Medicines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia OTC Pain Medicines Revenue by Region (US$ Million) & (2021-2026) Table 152. Asia OTC Pain Medicines Revenue by Region (US$ Million) & (2027-2032) Table 153. SAMEA OTC Pain Medicines Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA OTC Pain Medicines Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA OTC Pain Medicines Revenue by Application (2021-2026) & (US$ Million) Table 156. SAMEA OTC Pain Medicines Revenue by Application (2027-2032) & (US$ Million) Table 157. SAMEA OTC Pain Medicines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. SAMEA OTC Pain Medicines Revenue by Country (2021-2026) & (US$ Million) Table 159. SAMEA OTC Pain Medicines Revenue by Country (US$ Million) & (2027-2032) Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. OTC Pain Medicines Image Figure 2. Global OTC Pain Medicines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Pain Medicines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Naproxen Image Figure 5. Acetaminophen Image Figure 6. Ibuprofen Image Figure 7. Aspirin Image Figure 8. Others Image Figure 9. Global OTC Pain Medicines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global OTC Pain Medicines Market Size Share 2021 VS 2025 VS 2032 Figure 11. E-Commerce Image Figure 12. Drug Stores Image Figure 13. Hospital Pharmacies Image Figure 14. Global OTC Pain Medicines Market Size (US$ Million) & (2021-2032) Figure 15. Global OTC Pain Medicines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global OTC Pain Medicines Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global OTC Pain Medicines Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global OTC Pain Medicines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global OTC Pain Medicines Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global OTC Pain Medicines Revenue Market Share by Type (2021-2032) Figure 22. Global OTC Pain Medicines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global OTC Pain Medicines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global OTC Pain Medicines Revenue Market Share by Application (2021-2032) Figure 25. North America OTC Pain Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America OTC Pain Medicines Revenue Share by Type (2021-2032) Figure 27. North America OTC Pain Medicines Revenue Share by Application (2021-2032) Figure 28. North America OTC Pain Medicines Revenue Share by Country (2021-2032) Figure 29. United States OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe OTC Pain Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe OTC Pain Medicines Revenue Share by Type (2021-2032) Figure 34. Europe OTC Pain Medicines Revenue Share by Application (2021-2032) Figure 35. Europe OTC Pain Medicines Revenue Share by Country (2021-2032) Figure 36. Germany OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China OTC Pain Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China OTC Pain Medicines Revenue Share by Type (2021-2032) Figure 46. China OTC Pain Medicines Revenue Share by Application (2021-2032) Figure 47. Asia OTC Pain Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia OTC Pain Medicines Revenue Share by Type (2021-2032) Figure 49. Asia OTC Pain Medicines Revenue Share by Application (2021-2032) Figure 50. Asia OTC Pain Medicines Revenue Share by Region (2021-2032) Figure 51. Japan OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA OTC Pain Medicines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA OTC Pain Medicines Revenue Share by Type (2021-2032) Figure 59. SAMEA OTC Pain Medicines Revenue Share by Application (2021-2032) Figure 60. SAMEA OTC Pain Medicines Revenue Share by Country (2021-2032) Figure 61. Brazil OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt OTC Pain Medicines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Naproxen
  • Acetaminophen
  • Ibuprofen
  • Aspirin
  • Others
Applications
  • E-Commerce
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • Zhejiang Kangle
  • Xinhua Pharmaceutical
  • Sanofi
  • Novartis
  • Pfizer
  • Hebei Jiheng
  • GlaxoSmithKline
  • Bayer
  • Anhui BBCA Likang
  • Strides Shasun
  • Sri Krishna Pharma
  • Seqens
  • Mallinckrodt
  • IOLCP
  • Granules India
  • Granules Biocause
  • Farmson
  • Anqiu Lu'an

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 OTC Pain Medicines Market by Type
  3. 1.2.1 Global OTC Pain Medicines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Naproxen
  5. 1.2.3 Acetaminophen
  6. 1.2.4 Ibuprofen
  7. 1.2.5 Aspirin
  8. 1.2.6 Others
  9. 1.3 OTC Pain Medicines Market by Application
  10. 1.3.1 Global OTC Pain Medicines Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 E-Commerce
  12. 1.3.3 Drug Stores
  13. 1.3.4 Hospital Pharmacies
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 OTC Pain Medicines Market Dynamics
  1. 2.1 OTC Pain Medicines Industry Trends
  2. 2.2 OTC Pain Medicines Industry Drivers
  3. 2.3 OTC Pain Medicines Industry Opportunities and Challenges
  4. 2.4 OTC Pain Medicines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global OTC Pain Medicines Market Perspective (2021-2032)
  2. 3.2 Global OTC Pain Medicines Growth Trends by Region
  3. 3.2.1 Global OTC Pain Medicines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global OTC Pain Medicines Market Size by Region (2021-2026)
  5. 3.2.3 Global OTC Pain Medicines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global OTC Pain Medicines Revenue by Players
  2. 4.1.1 Global OTC Pain Medicines Revenue by Players (2021-2026)
  3. 4.1.2 Global OTC Pain Medicines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global OTC Pain Medicines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global OTC Pain Medicines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global OTC Pain Medicines Key Players Headquarters & Area Served
  7. 4.4 Global OTC Pain Medicines Players, Product Type & Application
  8. 4.5 Global OTC Pain Medicines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global OTC Pain Medicines Market CR5 and HHI
  11. 4.6.3 2025 OTC Pain Medicines Tier 1, Tier 2, and Tier 3
5 OTC Pain Medicines Market Size by Type
  1. 5.1 Global OTC Pain Medicines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global OTC Pain Medicines Revenue by Type (2021-2032)
  3. 5.3 Global OTC Pain Medicines Revenue Market Share by Type (2021-2032)
6 OTC Pain Medicines Market Size by Application
  1. 6.1 Global OTC Pain Medicines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global OTC Pain Medicines Revenue by Application (2021-2032)
  3. 6.3 Global OTC Pain Medicines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Zhejiang Kangle
  2. 7.1.1 Zhejiang Kangle Company Information
  3. 7.1.2 Zhejiang Kangle Business Overview
  4. 7.1.3 Zhejiang Kangle OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Kangle OTC Pain Medicines Product Portfolio
  6. 7.1.5 Zhejiang Kangle Recent Developments
  7. 7.2 Xinhua Pharmaceutical
  8. 7.2.1 Xinhua Pharmaceutical Company Information
  9. 7.2.2 Xinhua Pharmaceutical Business Overview
  10. 7.2.3 Xinhua Pharmaceutical OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Xinhua Pharmaceutical OTC Pain Medicines Product Portfolio
  12. 7.2.5 Xinhua Pharmaceutical Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi OTC Pain Medicines Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Novartis OTC Pain Medicines Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer OTC Pain Medicines Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Hebei Jiheng
  32. 7.6.1 Hebei Jiheng Company Information
  33. 7.6.2 Hebei Jiheng Business Overview
  34. 7.6.3 Hebei Jiheng OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Hebei Jiheng OTC Pain Medicines Product Portfolio
  36. 7.6.5 Hebei Jiheng Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline OTC Pain Medicines Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Bayer
  44. 7.8.1 Bayer Company Information
  45. 7.8.2 Bayer Business Overview
  46. 7.8.3 Bayer OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bayer OTC Pain Medicines Product Portfolio
  48. 7.8.5 Bayer Recent Developments
  49. 7.9 Anhui BBCA Likang
  50. 7.9.1 Anhui BBCA Likang Company Information
  51. 7.9.2 Anhui BBCA Likang Business Overview
  52. 7.9.3 Anhui BBCA Likang OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Anhui BBCA Likang OTC Pain Medicines Product Portfolio
  54. 7.9.5 Anhui BBCA Likang Recent Developments
  55. 7.10 Strides Shasun
  56. 7.10.1 Strides Shasun Company Information
  57. 7.10.2 Strides Shasun Business Overview
  58. 7.10.3 Strides Shasun OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Strides Shasun OTC Pain Medicines Product Portfolio
  60. 7.10.5 Strides Shasun Recent Developments
  61. 7.11 Sri Krishna Pharma
  62. 7.11.1 Sri Krishna Pharma Company Information
  63. 7.11.2 Sri Krishna Pharma Business Overview
  64. 7.11.3 Sri Krishna Pharma OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sri Krishna Pharma OTC Pain Medicines Product Portfolio
  66. 7.11.5 Sri Krishna Pharma Recent Developments
  67. 7.12 Seqens
  68. 7.12.1 Seqens Company Information
  69. 7.12.2 Seqens Business Overview
  70. 7.12.3 Seqens OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Seqens OTC Pain Medicines Product Portfolio
  72. 7.12.5 Seqens Recent Developments
  73. 7.13 Mallinckrodt
  74. 7.13.1 Mallinckrodt Company Information
  75. 7.13.2 Mallinckrodt Business Overview
  76. 7.13.3 Mallinckrodt OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Mallinckrodt OTC Pain Medicines Product Portfolio
  78. 7.13.5 Mallinckrodt Recent Developments
  79. 7.14 IOLCP
  80. 7.14.1 IOLCP Company Information
  81. 7.14.2 IOLCP Business Overview
  82. 7.14.3 IOLCP OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  83. 7.14.4 IOLCP OTC Pain Medicines Product Portfolio
  84. 7.14.5 IOLCP Recent Developments
  85. 7.15 Granules India
  86. 7.15.1 Granules India Company Information
  87. 7.15.2 Granules India Business Overview
  88. 7.15.3 Granules India OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Granules India OTC Pain Medicines Product Portfolio
  90. 7.15.5 Granules India Recent Developments
  91. 7.16 Granules Biocause
  92. 7.16.1 Granules Biocause Company Information
  93. 7.16.2 Granules Biocause Business Overview
  94. 7.16.3 Granules Biocause OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Granules Biocause OTC Pain Medicines Product Portfolio
  96. 7.16.5 Granules Biocause Recent Developments
  97. 7.17 Farmson
  98. 7.17.1 Farmson Company Information
  99. 7.17.2 Farmson Business Overview
  100. 7.17.3 Farmson OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Farmson OTC Pain Medicines Product Portfolio
  102. 7.17.5 Farmson Recent Developments
  103. 7.18 Anqiu Lu'an
  104. 7.18.1 Anqiu Lu'an Company Information
  105. 7.18.2 Anqiu Lu'an Business Overview
  106. 7.18.3 Anqiu Lu'an OTC Pain Medicines Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Anqiu Lu'an OTC Pain Medicines Product Portfolio
  108. 7.18.5 Anqiu Lu'an Recent Developments
8 North America
  1. 8.1 North America OTC Pain Medicines Revenue (2021-2032)
  2. 8.2 North America OTC Pain Medicines Revenue by Type (2021-2032)
  3. 8.2.1 North America OTC Pain Medicines Revenue by Type (2021-2026)
  4. 8.2.2 North America OTC Pain Medicines Revenue by Type (2027-2032)
  5. 8.3 North America OTC Pain Medicines Revenue Share by Type (2021-2032)
  6. 8.4 North America OTC Pain Medicines Revenue by Application (2021-2032)
  7. 8.4.1 North America OTC Pain Medicines Revenue by Application (2021-2026)
  8. 8.4.2 North America OTC Pain Medicines Revenue by Application (2027-2032)
  9. 8.5 North America OTC Pain Medicines Revenue Share by Application (2021-2032)
  10. 8.6 North America OTC Pain Medicines Revenue by Country
  11. 8.6.1 North America OTC Pain Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America OTC Pain Medicines Revenue by Country (2021-2026)
  13. 8.6.3 North America OTC Pain Medicines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe OTC Pain Medicines Revenue (2021-2032)
  2. 9.2 Europe OTC Pain Medicines Revenue by Type (2021-2032)
  3. 9.2.1 Europe OTC Pain Medicines Revenue by Type (2021-2026)
  4. 9.2.2 Europe OTC Pain Medicines Revenue by Type (2027-2032)
  5. 9.3 Europe OTC Pain Medicines Revenue Share by Type (2021-2032)
  6. 9.4 Europe OTC Pain Medicines Revenue by Application (2021-2032)
  7. 9.4.1 Europe OTC Pain Medicines Revenue by Application (2021-2026)
  8. 9.4.2 Europe OTC Pain Medicines Revenue by Application (2027-2032)
  9. 9.5 Europe OTC Pain Medicines Revenue Share by Application (2021-2032)
  10. 9.6 Europe OTC Pain Medicines Revenue by Country
  11. 9.6.1 Europe OTC Pain Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe OTC Pain Medicines Revenue by Country (2021-2026)
  13. 9.6.3 Europe OTC Pain Medicines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China OTC Pain Medicines Revenue (2021-2032)
  2. 10.2 China OTC Pain Medicines Revenue by Type (2021-2032)
  3. 10.2.1 China OTC Pain Medicines Revenue by Type (2021-2026)
  4. 10.2.2 China OTC Pain Medicines Revenue by Type (2027-2032)
  5. 10.3 China OTC Pain Medicines Revenue Share by Type (2021-2032)
  6. 10.4 China OTC Pain Medicines Revenue by Application (2021-2032)
  7. 10.4.1 China OTC Pain Medicines Revenue by Application (2021-2026)
  8. 10.4.2 China OTC Pain Medicines Revenue by Application (2027-2032)
  9. 10.5 China OTC Pain Medicines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia OTC Pain Medicines Revenue (2021-2032)
  2. 11.2 Asia OTC Pain Medicines Revenue by Type (2021-2032)
  3. 11.2.1 Asia OTC Pain Medicines Revenue by Type (2021-2026)
  4. 11.2.2 Asia OTC Pain Medicines Revenue by Type (2027-2032)
  5. 11.3 Asia OTC Pain Medicines Revenue Share by Type (2021-2032)
  6. 11.4 Asia OTC Pain Medicines Revenue by Application (2021-2032)
  7. 11.4.1 Asia OTC Pain Medicines Revenue by Application (2021-2026)
  8. 11.4.2 Asia OTC Pain Medicines Revenue by Application (2027-2032)
  9. 11.5 Asia OTC Pain Medicines Revenue Share by Application (2021-2032)
  10. 11.6 Asia OTC Pain Medicines Revenue by Country
  11. 11.6.1 Asia OTC Pain Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia OTC Pain Medicines Revenue by Country (2021-2026)
  13. 11.6.3 Asia OTC Pain Medicines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA OTC Pain Medicines Revenue (2021-2032)
  2. 12.2 SAMEA OTC Pain Medicines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA OTC Pain Medicines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA OTC Pain Medicines Revenue by Type (2027-2032)
  5. 12.3 SAMEA OTC Pain Medicines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA OTC Pain Medicines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA OTC Pain Medicines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA OTC Pain Medicines Revenue by Application (2027-2032)
  9. 12.5 SAMEA OTC Pain Medicines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA OTC Pain Medicines Revenue by Country
  11. 12.6.1 SAMEA OTC Pain Medicines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA OTC Pain Medicines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA OTC Pain Medicines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst